{"id":17054,"date":"2021-11-02T07:39:13","date_gmt":"2021-11-02T14:39:13","guid":{"rendered":"https:\/\/ameripharmaspe.wpengine.com\/?p=17054"},"modified":"2026-01-22T10:30:46","modified_gmt":"2026-01-22T17:30:46","slug":"introduction-to-cll","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/introduction-to-cll\/","title":{"rendered":"Introducci\u00f3n a la leucemia linfoc\u00edtica cr\u00f3nica (LLC)"},"content":{"rendered":"<p>La leucemia linfoc\u00edtica cr\u00f3nica (LLC) es un c\u00e1ncer de crecimiento lento que se origina en la sangre y la m\u00e9dula \u00f3sea. Afecta principalmente a un tipo de gl\u00f3bulo blanco llamado... <a href=\"https:\/\/my.clevelandclinic.org\/health\/body\/24669-b-cells\">linfocito B<\/a>Si bien la LLC es una de las leucemias m\u00e1s comunes en adultos, sigue siendo relativamente poco frecuente en general: aproximadamente 23,000 personas en EE. UU. reciben el diagn\u00f3stico cada a\u00f1o, lo que representa solo el 1-2% de todos los c\u00e1nceres. La mayor\u00eda de las personas tienen alrededor de 70 a\u00f1os al momento del diagn\u00f3stico, y es extremadamente rara en ni\u00f1os.<\/p>\n\n\n\n<div  id=\"call-to-action-d6ba2261c28f273ac073740cbd2b8101\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el copago de IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>La m\u00e9dula \u00f3sea, el tejido blando y esponjoso que se encuentra dentro de los huesos, es como una f\u00e1brica de c\u00e9lulas sangu\u00edneas. Alberga c\u00e9lulas madre que pueden convertirse en... <strong>c\u00e9lulas madre mieloides<\/strong> o <strong>c\u00e9lulas madre linfoides<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>C\u00e9lulas madre mieloides<\/strong> producir gl\u00f3bulos rojos (transportan ox\u00edgeno), granulocitos y monocitos (combaten bacterias y hongos, limpian restos celulares) y plaquetas (ayudan a la coagulaci\u00f3n sangu\u00ednea).<\/li>\n\n\n\n<li><strong>C\u00e9lulas madre linfoides<\/strong> producir c\u00e9lulas B (producen anticuerpos), c\u00e9lulas T (ayudan a coordinar la respuesta inmune) y c\u00e9lulas asesinas naturales (destruyen las c\u00e9lulas infectadas por virus y cancerosas).<\/li>\n<\/ul>\n\n\n\n<p>En la LLC, algunos linfocitos B crecen, no maduran completamente y sobreviven durante un tiempo anormalmente largo. Estas c\u00e9lulas leuc\u00e9micas no pueden combatir eficazmente las infecciones y, a medida que se acumulan, desplazan a las c\u00e9lulas sangu\u00edneas sanas.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/introduction-to-cll\/#CLL_Causes_and_Risk_Factors\" >Causas y factores de riesgo de la LLC<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/introduction-to-cll\/#Symptoms_of_CLL\" >S\u00edntomas de la LLC<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/introduction-to-cll\/#Diagnosis\" >Diagn\u00f3stico<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/introduction-to-cll\/#Life_Expectancy_in_Patients_With_CLL\" >Esperanza de vida en pacientes con LLC<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/introduction-to-cll\/#Treatment_Options_for_CLL\" >Opciones de tratamiento para la LLC<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/introduction-to-cll\/#Most_Effective_Treatment_Plans_for_CLL\" >Los planes de tratamiento m\u00e1s eficaces para la LLC<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"CLL_Causes_and_Risk_Factors\"><\/span>Causas y factores de riesgo de la LLC<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Los m\u00e9dicos desconocen la causa exacta de la LLC. No est\u00e1 estrechamente relacionada con la radiaci\u00f3n, las infecciones ni la dieta. Lo que s\u00ed sabemos es que ciertos factores aumentan el riesgo:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Edad:<\/strong> El riesgo aumenta con la edad.<\/li>\n\n\n\n<li><strong>G\u00e9nero:<\/strong> La LLC es ligeramente m\u00e1s com\u00fan en varones.<\/li>\n\n\n\n<li><strong>Carrera:<\/strong> La LLC es m\u00e1s com\u00fan en personas blancas.<\/li>\n\n\n\n<li><strong>Historia familiar:<\/strong> Tener un pariente cercano con LLC aumenta sus probabilidades.<\/li>\n\n\n\n<li><strong>Exposici\u00f3n qu\u00edmica:<\/strong> La exposici\u00f3n prolongada a ciertos herbicidas o insecticidas puede desempe\u00f1ar un papel.<\/li>\n<\/ul>\n\n\n\n<div  id=\"call-to-action-af183b41dfeab36ecb866d6fb8040890\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tInformaci\u00f3n del tratamiento\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tObtenga autorizaci\u00f3n previa para IgIV\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Obtenga una evaluaci\u00f3n gratuita<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Symptoms_of_CLL\"><\/span>S\u00edntomas de la LLC<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Inicialmente, la LLC no presenta s\u00edntomas, pero estos comienzan a aparecer a medida que la enfermedad progresa. Los siguientes son los s\u00edntomas m\u00e1s comunes que pueden presentarse en pacientes con LLC:&nbsp;<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Ganglios linf\u00e1ticos agrandados<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Infecciones frecuentes<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">P\u00e9rdida de peso inexplicable<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Debilidad\/sensaci\u00f3n de cansancio<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor corporal<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">sudores nocturnos&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Anemia<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Temperatura alta<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Diagnosis\"><\/span>Diagn\u00f3stico<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La LLC no es una prueba que los m\u00e9dicos suelan realizar. La mayor\u00eda de las personas descubren que la tienen cuando un an\u00e1lisis de sangre de rutina muestra un recuento elevado de linfocitos. A partir de ah\u00ed, el m\u00e9dico solicitar\u00e1 m\u00e1s pruebas para confirmar el diagn\u00f3stico y planificar el tratamiento.<\/p>\n\n\n\n<p>Esto a menudo incluye:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>An\u00e1lisis de sangre:<\/strong> A <a href=\"https:\/\/www.mayoclinic.org\/tests-procedures\/complete-blood-count\/about\/pac-20384919\">CBC<\/a> para comprobar el recuento de c\u00e9lulas y <strong>citometr\u00eda de flujo<\/strong> para ver si los linfocitos son c\u00e9lulas LLC.<\/li>\n\n\n\n<li><strong>Pruebas gen\u00e9ticas y moleculares:<\/strong> Busca mutaciones de TP53, del(17p) y el estado de IGHV, que ayudan a predecir c\u00f3mo se comportar\u00e1 la enfermedad y qu\u00e9 tratamientos funcionar\u00e1n mejor.<\/li>\n\n\n\n<li><strong>Examen f\u00edsico:<\/strong> Comprobaci\u00f3n de ganglios linf\u00e1ticos agrandados, h\u00edgado o bazo.<\/li>\n\n\n\n<li><strong>Im\u00e1genes:<\/strong> A veces se utilizan tomograf\u00edas computarizadas si existe preocupaci\u00f3n por ganglios linf\u00e1ticos inflamados o agrandamiento de \u00f3rganos.<\/li>\n<\/ul>\n\n\n\n<p><strong>Biopsia:<\/strong> La biopsia de m\u00e9dula \u00f3sea o de ganglio linf\u00e1tico s\u00f3lo se realiza si los an\u00e1lisis de sangre dejan preguntas sin respuesta.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Life_Expectancy_in_Patients_With_CLL\"><\/span>Esperanza de vida en pacientes con LLC<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">T<\/span>Gracias a los importantes avances en el tratamiento, las personas con LLC viven m\u00e1s que nunca. En EE. UU., la tasa de supervivencia general a 5 a\u00f1os es de aproximadamente 89%, y muchas viven d\u00e9cadas despu\u00e9s del diagn\u00f3stico. El pron\u00f3stico depende de factores como la edad, el estado de salud general y las caracter\u00edsticas gen\u00e9ticas espec\u00edficas de la leucemia. Algunas personas nunca necesitan tratamiento, mientras que otras pueden requerirlo poco despu\u00e9s del diagn\u00f3stico.<\/p>\n\n\n\n<div  id=\"call-to-action-1b75d3f147a7d45a12fd22325ec20164\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el copago de IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAsistencia financiera para la IgIV\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Treatment_Options_for_CLL\"><\/span>Opciones de tratamiento para la LLC<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>No todas las personas con LLC necesitan tratamiento inmediato. Si no presenta s\u00edntomas, su m\u00e9dico podr\u00eda recomendarle... <strong>espera vigilante<\/strong> \u2014 chequeos regulares para monitorear su salud.<\/p>\n\n\n\n<p>Cuando llega el momento de iniciar el tratamiento, las opciones a las que se recurre actualmente son: <strong>medicamentos dirigidos<\/strong> en lugar de la quimioterapia tradicional:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Inhibidores de BTK<\/strong> (acalabrutinib, pirtobrutinib, ibrutinib o zanubrutinib): pastillas que se toman una o dos veces al d\u00eda<\/li>\n\n\n\n<li><strong>Inhibidores de BCL-2<\/strong> (venetoclax): pastillas que se toman t\u00edpicamente una vez al d\u00eda<\/li>\n\n\n\n<li><strong>Inhibidores de PI3K<\/strong> (Idelalisib, duvelisib): pastillas que se toman dos veces al d\u00eda,<\/li>\n<\/ul>\n\n\n\n<p>Su m\u00e9dico le ayudar\u00e1 a decidir cu\u00e1l es el mejor tratamiento para usted en funci\u00f3n de pruebas gen\u00e9ticas, otros problemas de salud y su preferencia por un tratamiento continuo o de duraci\u00f3n limitada.<\/p>\n\n\n\n<p><strong>Otras terapias<\/strong> incluir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Inmunoterapia:<\/strong> Los anticuerpos monoclonales como <a href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/rituximab-rituxan\/\">rituximab<\/a>, obinutuzumab u ofatumumab, generalmente administrados con otras terapias dirigidas.<\/li>\n\n\n\n<li><strong>Quimioterapia:<\/strong> Actualmente se utiliza principalmente para un grupo peque\u00f1o de pacientes m\u00e1s j\u00f3venes, muy en forma y con gen\u00e9tica favorable.<\/li>\n\n\n\n<li><strong>Radioterapia:<\/strong> Se utiliza para reducir el tama\u00f1o de los ganglios inflamados o del bazo para aliviar los s\u00edntomas.<\/li>\n\n\n\n<li><strong>Trasplante de c\u00e9lulas madre:<\/strong> Es la \u00fanica cura potencial, pero conlleva un alto riesgo y se utiliza en casos selectos.<\/li>\n<\/ul>\n\n\n\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\"><strong>Terapia con IgIV<\/strong><\/a><strong>:<\/strong> Para personas con niveles bajos de anticuerpos e infecciones frecuentes: ayuda a prevenir infecciones pero no prolonga la supervivencia.<\/p>\n\n\n\n<div  id=\"call-to-action-e92708ffa4173b85fa003f0afd59defd\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tConsulte a un especialista en IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tLa mejor infusi\u00f3n de IgIV en casa | Obtenga asistencia para el tratamiento con IgIV\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Most_Effective_Treatment_Plans_for_CLL\"><\/span>Los planes de tratamiento m\u00e1s eficaces para la LLC<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Los protocolos de tratamiento pueden cambiar seg\u00fan el estadio y la gravedad del c\u00e1ncer, as\u00ed como el estado de salud general del paciente. Las opciones de tratamiento para pacientes de alto riesgo son diferentes a las de otros pacientes.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Algunos posibles planes de tratamiento diferentes son:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><b>Trasplante de c\u00e9lulas madre.<\/b><span style=\"font-weight: 400;\"> Esta es una opci\u00f3n si la salud f\u00edsica y la condici\u00f3n f\u00edsica del paciente lo permiten.&nbsp;<\/span><\/li>\n\n\n\n<li><b>Alemtuzumab, un anticuerpo monoclonal.<\/b><span style=\"font-weight: 400;\"> La monoterapia con este f\u00e1rmaco demostr\u00f3 ser muy eficaz en m\u00e1s del 60% de pacientes con LCC. Su eficacia est\u00e1 demostrada en m\u00faltiples estudios.&nbsp;<\/span><\/li>\n\n\n\n<li><b>Ibrutinib (Imbruvica)<\/b><span style=\"font-weight: 400;\">Este medicamento se puede utilizar como monoterapia o en combinaci\u00f3n con rituximab (Rituxan), que puede ser una mejor opci\u00f3n para tratar el linfoma.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">&nbsp;<\/span><b>Venetoclax (Venclexta).<\/b><span style=\"font-weight: 400;\"> El venetoclax puede utilizarse como monoterapia o en combinaci\u00f3n con obinutuzumab (un anticuerpo monoclonal), seg\u00fan la afecci\u00f3n del paciente y el estadio del c\u00e1ncer. El venetoclax tambi\u00e9n se utiliza en combinaci\u00f3n con rituximab.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Muchas complicaciones se asocian con la quimioterapia y deben controlarse con un f\u00e1rmaco anticanceroso adecuado. Se utilizan otros f\u00e1rmacos seg\u00fan las complicaciones del paciente.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>La leucemia linfoc\u00edtica cr\u00f3nica (LLC) es un c\u00e1ncer de crecimiento lento que se origina en la sangre y la m\u00e9dula \u00f3sea. Afecta principalmente a un tipo de gl\u00f3bulo blanco llamado linfocito B. Si bien la LCC es una de las leucemias m\u00e1s comunes en adultos, sigue siendo relativamente poco frecuente en general: afecta a unas 23\u00a0000 personas en EE. UU.<\/p>","protected":false},"author":27,"featured_media":17799,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[13],"tags":[33],"class_list":["post-17054","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","tag-dr-samantha-kaeberlein"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Intro to Chronic Lymphocytic Leukemia (CLL)<\/title>\n<meta name=\"description\" content=\"Chronic lymphocytic leukemia (CLL) is a cancer of the blood and bone marrow cells that generally develops gradually.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/introduction-to-cll\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Intro to Chronic Lymphocytic Leukemia (CLL)\" \/>\n<meta property=\"og:description\" content=\"Chronic lymphocytic leukemia (CLL) is a cancer of the blood and bone marrow cells that generally develops gradually.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/introduction-to-cll\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-02T14:39:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-22T17:30:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Samantha Kaeberlein, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Samantha Kaeberlein, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/introduction-to-cll\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/introduction-to-cll\\\/\"},\"author\":{\"name\":\"Dr. Samantha Kaeberlein, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/aa941bb470287e10309b2fe7f5b15430\"},\"headline\":\"Intro to Chronic Lymphocytic Leukemia (CLL)\",\"datePublished\":\"2021-11-02T14:39:13+00:00\",\"dateModified\":\"2026-01-22T17:30:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/introduction-to-cll\\\/\"},\"wordCount\":886,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/introduction-to-cll\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/cll.jpg\",\"keywords\":[\"Dr. Samantha Kaeberlein\"],\"articleSection\":[\"Cancer\"],\"inLanguage\":\"es\"},{\"@type\":[\"WebPage\",\"MedicalWebPage\"],\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/introduction-to-cll\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/introduction-to-cll\\\/\",\"name\":\"Intro to Chronic Lymphocytic Leukemia (CLL)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/introduction-to-cll\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/introduction-to-cll\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/cll.jpg\",\"datePublished\":\"2021-11-02T14:39:13+00:00\",\"dateModified\":\"2026-01-22T17:30:46+00:00\",\"description\":\"Chronic lymphocytic leukemia (CLL) is a cancer of the blood and bone marrow cells that generally develops gradually.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/introduction-to-cll\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/introduction-to-cll\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/introduction-to-cll\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/cll.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/cll.jpg\",\"width\":1280,\"height\":853,\"caption\":\"cll\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/introduction-to-cll\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Intro to Chronic Lymphocytic Leukemia (CLL)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/aa941bb470287e10309b2fe7f5b15430\",\"name\":\"Dr. Samantha Kaeberlein, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"caption\":\"Dr. Samantha Kaeberlein, PharmD\"},\"description\":\"Dr. Samantha Kaeberlein, PharmD was born and raised in Canton, OH. She received her pharmacy degree from Northeast Ohio Medical University (NEOMED) in 2020. The most rewarding part of her job is providing medical guidance so patients can make informed, well-rounded decisions regarding their healthcare. Her areas of expertise are geriatrics and long-term care. In her free time, she enjoys spending time outdoors, reading, and hunting for the best cup of coffee in America.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/samantha\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Introducci\u00f3n a la leucemia linfoc\u00edtica cr\u00f3nica (LLC)","description":"La leucemia linfoc\u00edtica cr\u00f3nica (LLC) es un c\u00e1ncer de las c\u00e9lulas de la sangre y de la m\u00e9dula \u00f3sea que generalmente se desarrolla de forma gradual.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/introduction-to-cll\/","og_locale":"es_MX","og_type":"article","og_title":"Intro to Chronic Lymphocytic Leukemia (CLL)","og_description":"Chronic lymphocytic leukemia (CLL) is a cancer of the blood and bone marrow cells that generally develops gradually.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/introduction-to-cll\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2021-11-02T14:39:13+00:00","article_modified_time":"2026-01-22T17:30:46+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg","type":"image\/jpeg"}],"author":"Dr. Samantha Kaeberlein, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Samantha Kaeberlein, PharmD","Est. reading time":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/cancer\/introduction-to-cll\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/introduction-to-cll\/"},"author":{"name":"Dr. Samantha Kaeberlein, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/aa941bb470287e10309b2fe7f5b15430"},"headline":"Intro to Chronic Lymphocytic Leukemia (CLL)","datePublished":"2021-11-02T14:39:13+00:00","dateModified":"2026-01-22T17:30:46+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/introduction-to-cll\/"},"wordCount":886,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/introduction-to-cll\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg","keywords":["Dr. Samantha Kaeberlein"],"articleSection":["Cancer"],"inLanguage":"es"},{"@type":["WebPage","MedicalWebPage"],"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/introduction-to-cll\/","url":"https:\/\/ameripharmaspecialty.com\/cancer\/introduction-to-cll\/","name":"Introducci\u00f3n a la leucemia linfoc\u00edtica cr\u00f3nica (LLC)","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/introduction-to-cll\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/introduction-to-cll\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg","datePublished":"2021-11-02T14:39:13+00:00","dateModified":"2026-01-22T17:30:46+00:00","description":"La leucemia linfoc\u00edtica cr\u00f3nica (LLC) es un c\u00e1ncer de las c\u00e9lulas de la sangre y de la m\u00e9dula \u00f3sea que generalmente se desarrolla de forma gradual.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/introduction-to-cll\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/cancer\/introduction-to-cll\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/cancer\/introduction-to-cll\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg","width":1280,"height":853,"caption":"cll"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/cancer\/introduction-to-cll\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/es\/"},{"@type":"ListItem","position":2,"name":"Intro to Chronic Lymphocytic Leukemia (CLL)"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/aa941bb470287e10309b2fe7f5b15430","name":"Dra. Samantha Kaeberlein, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","caption":"Dr. Samantha Kaeberlein, PharmD"},"description":"La Dra. Samantha Kaeberlein, PharmD, naci\u00f3 y creci\u00f3 en Canton, Ohio. Obtuvo su t\u00edtulo en farmacia en la Universidad M\u00e9dica del Noreste de Ohio (NEOMED) en 2020. Lo m\u00e1s gratificante de su trabajo es brindar orientaci\u00f3n m\u00e9dica para que los pacientes puedan tomar decisiones informadas y completas sobre su atenci\u00f3n m\u00e9dica. Sus \u00e1reas de especializaci\u00f3n son la geriatr\u00eda y los cuidados a largo plazo. En su tiempo libre, disfruta de pasar tiempo al aire libre, leer y encontrar el mejor caf\u00e9 de Estados Unidos.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Samantha Kaeberlein, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"},"uagb_comment_info":3,"uagb_excerpt":"Chronic lymphocytic leukemia (CLL) is a slow-growing cancer that starts in the blood and bone marrow. It mainly affects a type of white blood cell called a B lymphocyte. While CLL is one of the most common leukemias in adults, it\u2019s still relatively rare overall \u2014 about 23,000 people in the U.S.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/cll.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Samantha Kaeberlein, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"},"rttpg_comment":3,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/cancer\/\" rel=\"category tag\">Cancer<\/a>","rttpg_excerpt":"Chronic lymphocytic leukemia (CLL) is a slow-growing cancer that starts in the blood and bone marrow. It mainly affects a type of white blood cell called a B lymphocyte. While CLL is one of the most common leukemias in adults, it\u2019s still relatively rare overall \u2014 about 23,000 people in the U.S.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/17054","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=17054"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/17054\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/17799"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=17054"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=17054"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=17054"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}